J2KBIO Future Growth
Future criteria checks 2/6
J2KBIO is forecast to grow revenue at 38.3% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 72.9% |
Revenue growth rate | 38.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 28 Aug 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 60,500 | N/A | N/A | N/A | 1 |
12/31/2024 | 48,100 | N/A | N/A | N/A | 1 |
9/30/2024 | 34,706 | -656 | -1,245 | 6,234 | N/A |
6/30/2024 | 35,922 | 1,009 | -284 | 4,163 | N/A |
3/31/2024 | 30,848 | -312 | 1,774 | 3,839 | N/A |
12/31/2023 | 28,472 | 4,844 | 1,698 | 3,285 | N/A |
9/30/2023 | 24,473 | 4,165 | 2,397 | 3,222 | N/A |
6/30/2023 | 21,088 | 3,356 | 2,534 | 2,733 | N/A |
3/31/2023 | 17,791 | 2,501 | 1,520 | 1,662 | N/A |
12/31/2022 | 16,032 | 2,086 | 1,268 | 1,448 | N/A |
12/31/2021 | 14,219 | 1,623 | 1,186 | 2,001 | N/A |
12/31/2020 | 13,858 | 1,475 | -1,159 | 852 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A420570's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A420570's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A420570's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A420570's revenue (38.3% per year) is forecast to grow faster than the KR market (9.4% per year).
High Growth Revenue: A420570's revenue (38.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A420570's Return on Equity is forecast to be high in 3 years time